Literature DB >> 8755648

Contributions of gluconeogenesis to glucose production in the fasted state.

B R Landau1, J Wahren, V Chandramouli, W C Schumann, K Ekberg, S C Kalhan.   

Abstract

Healthy subjects ingested 2H2O and after 14, 22, and 42 h of fasting the enrichments of deuterium in the hydrogens bound to carbons 2, 5, and 6 of blood glucose and in body water were determined. The hydrogens bound to the carbons were isolated in formaldehyde which was converted to hexamethylenetetramine for assay. Enrichment of the deuterium bound to carbon 5 of glucose to that in water or to carbon 2 directly equals the fraction of glucose formed by gluconeogenesis. The contribution of gluconeogenesis to glucose production was 47 +/- 49% after 14 h, 67 +/- 41% after 22 h, and 93 +/- 2% after 42 h of fasting. Glycerol's conversion to glucose is included in estimates using the enrichment at carbon 5, but not carbon 6. Equilibrations with water of the hydrogens bound to carbon 3 of pyruvate that become those bound to carbon 6 of glucose and of the hydrogen at carbon 2 of glucose produced via glycogenolysis are estimated from the enrichments to be approximately 80% complete. Thus, rates of gluconeogenesis can be determined without corrections required in other tracer methodologies. After an overnight fast gluconeogenesis accounts for approximately 50% and after 42 h of fasting for almost all of glucose production in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755648      PMCID: PMC507441          DOI: 10.1172/JCI118803

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

Review 1.  Gluconeogenesis: methodological approaches in vivo.

Authors:  J L Chiasson; J E Liljenquist; W W Lacy; A S Jennings; A D Cherrington
Journal:  Fed Proc       Date:  1977-02

2.  The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans.

Authors:  O Björkman; P Felig; J Wahren
Journal:  Diabetes       Date:  1980-08       Impact factor: 9.461

3.  Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man.

Authors:  A Consoli; F Kennedy; J Miles; J Gerich
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

4.  Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans.

Authors:  O Björkman; P Felig; J Wahren
Journal:  Clin Physiol       Date:  1984-06

5.  Hormonal control of substrate cycling in humans.

Authors:  H Miyoshi; G I Shulman; E J Peters; M H Wolfe; D Elahi; R R Wolfe
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Glucose and fructose 6-phosphate cycle in humans.

Authors:  S Karlander; A Roovete; M Vranić; S Efendić
Journal:  Am J Physiol       Date:  1986-11

7.  Glycogen: its mode of formation and contribution to hepatic glucose output in postabsorptive humans.

Authors:  W Pimenta; N Nurjhan; P A Jansson; M Stumvoll; J Gerich; M Korytkowski
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

8.  Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man.

Authors:  G I Shulman; P W Ladenson; M H Wolfe; E C Ridgway; R R Wolfe
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

9.  Influence of hyperthyroidism on splanchnic exchange of glucose and gluconeogenic precursors.

Authors:  J Wahren; A Wennlund; L H Nilsson; P Felig
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Active hepatic glycogen synthesis from gluconeogenic precursors despite high tissue levels of fructose 2,6-bisphosphate.

Authors:  M Kuwajima; S Golden; J Katz; R H Unger; D W Foster; J D McGarry
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

View more
  101 in total

1.  Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism.

Authors:  P She; M Shiota; K D Shelton; R Chalkley; C Postic; M A Magnuson
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Authors:  M K Hellerstein; R A Neese; P Linfoot; M Christiansen; S Turner; A Letscher
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men.

Authors:  Jeffrey D Browning; Jeannie Baxter; Santhosh Satapati; Shawn C Burgess
Journal:  J Lipid Res       Date:  2011-12-03       Impact factor: 5.922

Review 4.  The role of the liver in type 2 diabetes.

Authors:  Peter Staehr; Ole Hother-Nielsen; Henning Beck-Nielsen
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 5.  Cellular metabolism and disease: what do metabolic outliers teach us?

Authors:  Ralph J DeBerardinis; Craig B Thompson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

6.  Effects of visceral adiposity on glycerol pathways in gluconeogenesis.

Authors:  Ian J Neeland; Connor Hughes; Colby R Ayers; Craig R Malloy; Eunsook S Jin
Journal:  Metabolism       Date:  2016-11-27       Impact factor: 8.694

7.  Glucose turnover and gluconeogenesis in human pregnancy.

Authors:  S Kalhan; K Rossi; L Gruca; E Burkett; A O'Brien
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

8.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

Review 9.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

10.  Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Authors:  S Kehlenbrink; S Koppaka; M Martin; R Relwani; M-H Cui; J-H Hwang; Y Li; R Basu; M Hawkins; P Kishore
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.